The Pharma Letter

Latest Pharmaceutical News

Latest Biotechnology News

Latest Generics News

Boardroom

Mergers & Acquisitions

EXPERT VIEW: Pfizer and AstraZeneca, a marriage not to be – yet?

EXPERT VIEW: Pfizer and AstraZeneca, a marriage not to be – yet?

Mergers and acquisitions may excite the markets and shareholders on both sides but their record of success in delivering the anticipated benefits is not good, writes Stephen Archer, founder of Spring Partnerships.

Back to top